In conclusion, PU.1 has been demonstrated to activate autoimmunity and promote inflammation in some common autoimmune diseases, including RA, SLE, EAE, etc. PU.1 can affect the function of a variety of immune cells in these diseases (Table 1). This evidence concerns the gene SPI1 and systemic lupus erythematosus.